Dillard's (DDS) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
24 Feb, 2026Executive summary
Fiscal year net income was $570.2 million, or $36.42 per share, down from $593.5 million, or $36.82 per share, year-over-year.
Retail gross margin for the year was 40.8%, slightly down from 41.0% the prior year.
Cash and short-term investments at year-end totaled approximately $1.1 billion.
The largest dividend in company history was paid, with significant cash reserves maintained.
Financial highlights
Net sales for the year were $6.474 billion, nearly flat compared to $6.483 billion the previous year.
Comparable store sales and total retail sales were unchanged year-over-year.
Fourth quarter net income was $203.7 million ($13.05 per share), down from $214.4 million ($13.48 per share) year-over-year.
Fourth quarter total retail sales decreased 1%, with comparable store sales also down 1%.
Operating expenses for the year were $1.759 billion (27.2% of sales), up from $1.731 billion (26.7% of sales) year-over-year.
Outlook and guidance
Estimates for fiscal 2026 include depreciation and amortization of $175 million, rentals of $18 million, net interest income of $5 million, and capital expenditures of $130 million.
Latest events from Dillard's
- Merger approved with no shareholder dilution, maintaining governance and proportional ownership.DDS
Proxy filing20 Mar 2026 - Retail sales and net income rose 3% in Q3, with strong cash flow and a $30 special dividend.DDS
Q3 20255 Dec 2025 - Director nominee Warren A. Stephens resigned; board seat to remain vacant until replacement elected.DDS
Proxy Filing2 Dec 2025 - Shareholders are voting on reincorporation to Texas, aiming for legal, tax, and governance benefits.DDS
Proxy Filing2 Dec 2025 - 2025 proxy covers director elections, auditor ratification, pay-for-performance, and governance.DDS
Proxy Filing2 Dec 2025 - Proposal seeks shareholder approval to reincorporate from Delaware to Texas, preserving rights and reducing risk.DDS
Proxy Filing2 Dec 2025 - Director elections and auditor ratification headline the May 2025 annual meeting agenda.DDS
Proxy Filing2 Dec 2025 - Q2 2025 retail sales rose 1% with strong cash flow, stable EPS, and ongoing share repurchases.DDS
Q2 20255 Sep 2025 - Net income and sales fell, but gross margin stayed strong and a $25 dividend was declared.DDS
Q3 202413 Jun 2025